ArticleInternational journal of immunopathology and pharmacology

Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice.

Ling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.